tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Shandong Boan Biotechnology Completes Share Placement to Fund R&D and Growth

Story Highlights
Shandong Boan Biotechnology Completes Share Placement to Fund R&D and Growth

Elevate Your Investing Strategy:

Shandong Boan Biotechnology Company., Limited. Class H ( (HK:6955) ) has provided an announcement.

Shandong Boan Biotechnology Co., Ltd. has successfully completed the placement of 38,400,000 new shares, representing approximately 6.69% of the total issued shares, at a price of HK$10.42 per share. The placement raised approximately HK$395.60 million in net proceeds, which will be used for research and development, commercialization of products, and to replenish working capital.

More about Shandong Boan Biotechnology Company., Limited. Class H

Shandong Boan Biotechnology Co., Ltd. is a biotechnology company based in China. The company focuses on the research and development of innovative product candidates, including clinical trials for various antibodies and bispecific ADCs. It also engages in the commercialization of marketed and upcoming products.

Average Trading Volume: 12,906,288

Technical Sentiment Signal: Strong Buy

Current Market Cap: HK$7.6B

See more insights into 6955 stock on TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1